Evidence map›Paper›PMID 24755633›Full record

ArticleJournal of addiction medicine

Stimulant dependence and stimulant-associated psychosis: clinical characteristics and age of onset in a native American community sample.

David A Gilder, Ian R Gizer, Philip Lau, Cindy L Ehlers

Open access · greenAbstract read
In one paragraph

Article in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

David A GilderFrom the Molecular and Cellular Neuroscience Department (DAG, PL, CLE) and Department of Molecular and Experimental Medicine (CLE), The Scripps Research Institute, La Jolla, CA; and Department of Psychological Sciences (IRG), University of Missouri, Columbia.
Ian R Gizer
Philip Lau
Cindy L Ehlers
University of Missouri · US

Funding

Deep sequencing studies for cannabis and stimulant dependenceR01DA030976 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EHLERS, CINDY L, GELERNTER, JOEL · 2010 to 2014
$16.5M
RISK FACTORS FOR ALCOHOLISM IN NATIVE AMERICANSR37AA010201 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI EHLERS, CINDY L · 2007 to 2015
$7.0M
RISK FACTORS FOR ALCOHOLISM IN NATIVE AMERICANSR01AA010201 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI EHLERS, CINDY L · 1994 to 2006
$3.8M
Alcohol and Adult Development: Understanding Etiology and ConsequencesK05AA017242 · NIAAA · UNIVERSITY OF MISSOURI-COLUMBIA · PI SHER, KENNETH JAMES · 2007 to 2016
$2.1M
NIAAA NIH HHS AA010201NIAAA NIH HHS K05 AA017242NIAAA NIH HHS R01 AA010201NIAAA NIH HHS R37 AA010201NIDA NIH HHS DA030976NIDA NIH HHS R01 DA030976
6 · The paper itself

Abstract

objectivesNative Americans experience some of the highest rates of Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) stimulant dependence (SD) of all US ethnic groups. The present report examined the clinical characteristics and age of onset of stimulant use, SD, remission from SD, and stimulant-associated psychosis (SAP) in a Native American community sample.

methodsDemographic information, stimulant (methamphetamine or cocaine) use, and lifetime Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) psychiatric disorder diagnoses were assessed in 858 Native Americans. Logistic regression was used to assess the associations of demographic, stimulant use, and psychiatric disorder variables with SD, remission from SD, and SAP. Kaplan-Meier survival analyses were used to assess time from first use to the onset of SD.

resultsThe overall rate of SD was 33%, of remission from SD 73%, and of SAP 17%. Stimulant dependence was associated with older age, less current annual household income, fewer lifetime years of education, intravenous stimulant use, and earlier age of first stimulant use. Remission from SD was associated with older age, currently being married, and never having used stimulants intravenously. Attention-deficit/hyperactivity disorder (assessed as a lifetime disorder), increased number of years of daily stimulant use, and intravenous use were independently associated with SAP. Younger age at first use was significantly associated with shorter survival to the onset of SD.

conclusionsStimulant dependence is prevalent in this population and is associated with less income and education and an earlier age at first use. Intravenous stimulant use adds additional risk for SD, nonremission, and psychosis.

Indexed as

AdolescentAdultAgedAged, 80 and overAge of OnsetAmphetamine-Related DisordersCocaine-Related DisordersDiagnosis, Dual (Psychiatry)FemaleHumansIndians, North AmericanMaleMental DisordersMiddle AgedProtective FactorsPsychoses, Substance-Induced

Identifiers

PMID24755633
PMCPMC4122628
OpenAlexW2067228512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.